Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1996 Jan;80(1):40-8.
doi: 10.1136/bjo.80.1.40.

Analysis of visual field progression in glaucoma

Affiliations
Clinical Trial

Analysis of visual field progression in glaucoma

F W Fitzke et al. Br J Ophthalmol. 1996 Jan.

Abstract

Background: Despite the widespread use of computerised perimetry the diagnosis of visual field deterioration in following glaucoma patients over time remains particularly difficult. A new method of analysis using a novel graphical display of longitudinal field data is presented.

Methods: A linear regression model of the luminance sensitivity at each stimulus location against time of follow up transforms the quantitative data from a series of fields into a colour coded form which illustrates the spatial configuration of change to aid the interpretation of field loss. The method of analysis and the developed computer software (PROGRESSOR) is described. Comparison with STATPAC-2 glaucoma change probability analysis is given including levels of agreement between the techniques using series of fields of 10 eyes from patients with normal tension glaucoma.

Results: Examples of this new method compare well with STATPAC-2 analysis. The level of agreement between the techniques to separate progressing from stable retinal locations is good (kappa = 0.62; SE = 0.04).

Conclusions: This new technique, which combines the change in perimetric sensitivity over time with colour coding of significant change into one image may provide an efficient method to detect true progression in glaucomatous field loss.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biometrics. 1977 Mar;33(1):159-74 - PubMed
    1. Br J Ophthalmol. 1995 Mar;79(3):213-7 - PubMed
    1. Am J Ophthalmol. 1984 Oct 15;98(4):443-5 - PubMed
    1. Eye (Lond). 1990;4 ( Pt 4):557-62 - PubMed
    1. Eye (Lond). 1990;4 ( Pt 4):563-71 - PubMed

Publication types